Intranasal immunization with an adenovirus vaccine protects guinea pigs from Ebola virus transmission by infected animals

Antiviral Research

Volumn 116, Issue , 2015, Pages 17-19

  Wong, Gary ^a,b   Richardson, Jason S ^a   Cutts, Todd ^a   Qiu, Xiangguo ^a   Kobinger, Gary P ^a,b,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Ebola; Guinea pigs; Transmission; Vaccine

Indexed keywords

AD5 ZGP VACCINE; ADENOVIRUS VACCINE; EBOLA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; RECOMBINANT VACCINE; VIRUS ANTIBODY;

AFRICA; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; CONVALESCENCE; EBOLA HEMORRHAGIC FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; GUINEA PIG; HEALTH CARE PERSONNEL; HUMAN; IMMUNE RESPONSE; LD 50; LONG TERM EXPOSURE; MEDICAL PERSONNEL; NONHUMAN; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SPAIN; UNITED STATES; VACCINATION; VIRUS SHEDDING; VIRUS TRANSMISSION; WEIGHT REDUCTION; ADENOVIRIDAE; ANIMAL; BLOOD; DISEASE MODEL; EBOLAVIRUS; GENETICS; HEMORRHAGIC FEVER, EBOLA; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; TRANSMISSION; VIROLOGY;

ADENOVIRIDAE; ANIMALIA; CAVIA; EBOLA VIRUS;

ADENOVIRIDAE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; EBOLA VACCINES; EBOLAVIRUS; GUINEA PIGS; HEMORRHAGIC FEVER, EBOLA; INJECTIONS, INTRAMUSCULAR; VACCINATION; VACCINES, SYNTHETIC;

EID: 84922308921     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.01.001     Document Type: Article

References (15)

1. J.H. Choi, K. Jonsson-Schmunk, X. Qiu, D.J. Shedlock, J. Strong, J.X. Xu, K.L. Michie, J. Audet, L. Fernando, M.J. Myers, D. Weiner, I. Bajrovic, L.Q. Tran, G. Wong, A. Bello, G.P. Kobinger, S.C. Schafer, and M.A. Croyle A single dose respiratory recombinant adenovirus-based vaccine provides long-term protection for non-human primates from lethal Ebola infection Mol. Pharm. 2014
2. J. Cohen Containing the threat-don't forget Ebola PLoS Med 1 2004 e59
3. B.M. Connolly, K.E. Steele, K.J. Davis, T.W. Geisbert, W.M. Kell, N.K. Jaax, and P.B. Jahrling Pathogenesis of experimental Ebola virus infection in guinea pigs J. Infect. Dis. 179 Suppl. 1 1999 S203 S217
4. S.F. Dowell, R. Mukunu, T.G. Ksiazek, A.S. Khan, P.E. Rollin, and C.J. Peters Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit J. Infect. Dis. 179 Suppl. 1 1999 S87 S91
5. H. Feldmann, and T.W. Geisbert Ebola haemorrhagic fever Lancet 377 2011 849 862
6. T.W. Geisbert, M. Bailey, L. Hensley, C. Asiedu, J. Geisbert, D. Stanley, A. Honko, J. Johnson, S. Mulangu, M.G. Pau, J. Custers, J. Vellinga, J. Hendriks, P. Jahrling, M. Roederer, J. Goudsmit, R. Koup, and N.J. Sullivan Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge J. Virol. 85 2011 4222 4233
7. S.M. Jones, H. Feldmann, U. Stroher, J.B. Geisbert, L. Fernando, A. Grolla, H.D. Klenk, N.J. Sullivan, V.E. Volchkov, E.A. Fritz, K.M. Daddario, L.E. Hensley, P.B. Jahrling, and T.W. Geisbert Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses Nat. Med. 11 2005 786 790
8. E. Nwanegbo, E. Vardas, W. Gao, H. Whittle, H. Sun, D. Rowe, P.D. Robbins, and A. Gambotto Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States Clin. Diagn. Lab. Immunol. 11 2004 351 357
9. X. Qiu, G. Wong, L. Fernando, J. Audet, A. Bello, J. Strong, J.B. Alimonti, and G.P. Kobinger MAbs and Ad-vectored IFN-alpha therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms Sci. Transl. Med. 5 2013 207ra143
10. J.S. Richardson, S. Pillet, A.J. Bello, and G.P. Kobinger Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates J. Virol. 87 2013 3668 3677
11. J.S. Richardson, G. Wong, S. Pillet, S. Schindle, J. Ennis, J. Turner, J.E. Strong, and G.P. Kobinger Evaluation of different strategies for post-exposure treatment of Ebola virus infection in rodents J. Bioterror. Biodef. 2011
12. D.A. Stanley, A.N. Honko, C. Asiedu, J.C. Trefry, A.W. Lau-Kilby, J.C. Johnson, L. Hensley, V. Ammendola, A. Abbate, F. Grazioli, K.E. Foulds, C. Cheng, L. Wang, M.M. Donaldson, S. Colloca, A. Folgori, M. Roederer, G.J. Nabel, J. Mascola, A. Nicosia, R. Cortese, R.A. Koup, and N.J. Sullivan Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge Nat. Med. 20 2014 1126 1129
13. N.A. Twenhafel, C.I. Shaia, T.E. Bunton, J.D. Shamblin, S.E. Wollen, L.M. Pitt, D.R. Sizemore, M.M. Ogg, and S.C. Johnston Experimental aerosolized Guinea pig-adapted zaire ebolavirus (variant: mayinga) causes lethal pneumonia in Guinea pigs Vet. Pathol. 52 2015 21 25
14. G. Wong, X. Qiu, J.S. Richardson, T. Cutts, B. Collignon, J. Gren, J. Aviles, C. Embury-Hyatt, and G.P. Kobinger Ebola virus transmission in guinea pigs J. Virol. 2014
15. G. Wong, J.S. Richardson, S. Pillet, A. Patel, X. Qiu, J. Alimonti, J. Hogan, Y. Zhang, A. Takada, H. Feldmann, and G.P. Kobinger Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates Sci. Transl. Med. 4 2012 158ra146